These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5773321)

  • 41. [Electrolytes as determining factors of hemagglutination in myxovirus].
    Del Rey Calero J
    Med Trop (Madr); 1968; 44(2):197-220. PubMed ID: 4311370
    [No Abstract]   [Full Text] [Related]  

  • 42. [Assay of influenza serological antibodies by hemagglutination inhibition test: interest of using nonspecific inhibitor-insensitive antigens (author's transl)].
    Fattal-German M; German A; Fattal S
    Ann Pharm Fr; 1980; 38(1):27-33. PubMed ID: 6156631
    [No Abstract]   [Full Text] [Related]  

  • 43. [Inhibition of hemagglutination caused by influenza virus. VII. Effect of inhibitors on the virus & on erythrocytes].
    LACORTE JG
    Rev Bras Med; 1958 Nov; 15(11):777-80. PubMed ID: 13658620
    [No Abstract]   [Full Text] [Related]  

  • 44. Humoral and cell-mediated immune response to influenza virus. I. Experiments in mice.
    Semkow R; Loza-Tulimowska M; Wilczyński J; Brydak L; Zgorzelska K
    Acta Microbiol Pol; 1982; 31(2):185-94. PubMed ID: 6188341
    [No Abstract]   [Full Text] [Related]  

  • 45. [Inhibition of hemagglutination caused by influenza virus. III. Inhibition with chemical agents].
    LACORTE JG
    Rev Bras Med; 1958 Jun; 15(6):387-9. PubMed ID: 13658547
    [No Abstract]   [Full Text] [Related]  

  • 46. [On the inactivation of the A2 Hong-Kong influenza virus with gamma rays].
    De Flora S; Badolati G; Bernardi G
    G Ig Med Prev; 1969; 10(4):403-10. PubMed ID: 5406290
    [No Abstract]   [Full Text] [Related]  

  • 47. [Immunologic study of Myxovirus influenzae. Search for antibodies inhibiting hemagglutination in 95 serums of male patients at the Military Teaching Hospital Mohammed V (Rabat)].
    Henry M; Nejmi S
    Voen Med Zh; 1970 Aug; 8():445-52. PubMed ID: 5515341
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immunologic study of Myxovirus influenzae. Search for antibodies inhibiting hemagglutination in 95 serums of male patients at the Military Teaching Hospital Mohammed V (Rabat)].
    Henry M; Nejmi S
    Maroc Med; 1970 Jul; 537():445-52. PubMed ID: 5503094
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies on Influenza virus A-Torino 1-1968].
    Giuliani G; Paggi GC; Novara O
    G Mal Infett Parassit; 1968 Sep; 20(9):812-5. PubMed ID: 5710691
    [No Abstract]   [Full Text] [Related]  

  • 50. Interaction of influenza virus with blood platelets.
    Terada H; Baldini M; Ebbe S; Madoff MA
    Blood; 1966 Aug; 28(2):213-28. PubMed ID: 5913052
    [No Abstract]   [Full Text] [Related]  

  • 51. [Action of biochemical atmosphere on reproduction of influenza virus in tissue culture. VI. First data on the importance of the hydrogen ion concentration].
    RUFFILLI D
    Boll Soc Ital Biol Sper; 1952 Jul; 28(7):1397-400. PubMed ID: 13018787
    [No Abstract]   [Full Text] [Related]  

  • 52. Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus.
    Petro-Turnquist EM; Bullard BL; Pekarek MJ; Weaver EA
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiviral Effects of ABMA and DABMA against Influenza Virus In Vitro and In Vivo via Regulating the Endolysosomal Pathway and Autophagy.
    Liu H; Jiang C; Wu Y; Wu M; Wu J; Zhao G; Sun J; Huang X; Li J; Sheng R; Barbier J; Cintrat JC; Gillet D; Su W
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selecting and Using the Appropriate Influenza Vaccine for Each Individual.
    Sekiya T; Ohno M; Nomura N; Handabile C; Shingai M; Jackson DC; Brown LE; Kida H
    Viruses; 2021 May; 13(6):. PubMed ID: 34073843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Live Attenuated Cold-Adapted Influenza Vaccines.
    Subbarao K
    Cold Spring Harb Perspect Med; 2021 Sep; 11(9):. PubMed ID: 32253347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.
    Waring BM; Sjaastad LE; Fiege JK; Fay EJ; Reyes I; Moriarity B; Langlois RA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of high-yield influenza B virus vaccine viruses.
    Ping J; Lopes TJ; Neumann G; Kawaoka Y
    Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8296-E8305. PubMed ID: 27930325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human Influenza Virus Infections.
    Peteranderl C; Herold S; Schmoldt C
    Semin Respir Crit Care Med; 2016 Aug; 37(4):487-500. PubMed ID: 27486731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a stable liquid formulation of live attenuated influenza vaccine.
    White JA; Estrada M; Flood EA; Mahmood K; Dhere R; Chen D
    Vaccine; 2016 Jul; 34(32):3676-83. PubMed ID: 27155495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias.
    Fan RL; Valkenburg SA; Wong CK; Li OT; Nicholls JM; Rabadan R; Peiris JS; Poon LL
    J Virol; 2015 Nov; 89(21):10762-73. PubMed ID: 26269186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.